Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy (PSP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02716168 |
Recruitment Status :
Completed
First Posted : March 23, 2016
Last Update Posted : October 20, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cancer | Other: Shared video consultation between patient, general practitioner and oncologist | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 281 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Investigator, Outcomes Assessor) |
Primary Purpose: | Health Services Research |
Official Title: | Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy - a Randomized Controlled Trial |
Actual Study Start Date : | May 2016 |
Actual Primary Completion Date : | August 2020 |
Actual Study Completion Date : | August 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: Video consultation
Video consultation between cancer patient, general practitioner and oncologist at the start of chemotherapy treatment
|
Other: Shared video consultation between patient, general practitioner and oncologist
At the start of the patients chemotherapy treatment a shared video consultation between the patient, general practitioner and oncologist will bee arranged. The video consultation should address distribution of roles, comorbidity, medicine, depression and anxiety symptoms, relatives and social resources. |
No Intervention: usual care
Usual care. The patients General Practitioner will receive standard discharge summary and ambulant notes from the oncologist specialist
|
- Shared Care questionnaire [ Time Frame: 7 month after inclusion ]Patient reported outcome measure. Cancer patients assessment of their cancer trajectory and their assessment of the cooperation between their General Practitioner and the oncologist specialist.
- Illness Intrusiveness Rating Scale (IIRS) [ Time Frame: 4 and 7 month after inclusion ]Patient reported outcome measure. Patients assessment of the cancer disease influence on their daily living.
- European Organisation for Research and Treatment of Cancer - Quality of Life questionnaire - Core 30 (EORTC QLQ C30) [ Time Frame: 4 and 7 month after inclusion ]Patient reported outcome measure. Cancer patients assessment of their quality of life
- European Organisation for Research and Treatment of Cancer - Quality of Life- information questionnaire (EORTC QLQ INFO25) [ Time Frame: 4 and 7 month after inclusion ]
- Generalised Anxiety Disorder Assessment (GAD-7) [ Time Frame: 4 and 7 month after inclusion ]Patient reported outcome measure. Screening tool and severity measure for generalised anxiety disorder
- Patient Health Questionnaire (PHQ-9) [ Time Frame: 4 and 7 month after inclusion ]Patient reported outcome measure.The questionnaire monitor the severity of depression and response to treatment.
- Oncologist assessment of a video consultation between the patient, General practitioner and oncologist. [ Time Frame: Directly after the video consultation intervention ]It measures the oncologist perception of the benefits with the video consultation intervention. Only the intervention group
- General practitioners assessment of a video consultation between the patient, General practitioner and oncologist. [ Time Frame: Directly after the video consultation intervention ]It measures the General Practitioners perception of the benefits with the video consultation intervention. Only the intervention group.
- Patients assessment of a video consultation between the patient, General practitioner and oncologist. [ Time Frame: Directly after the video consultation intervention ]It measures the patients perception of the benefits with the video consultation intervention.Only the intervention group
- General Practitioner cancer trajectory assessment [ Time Frame: 4 month after the inclusion of the patient. ]The General Practitioners assessment of the cooperation between the primary and secondary care regarding af specific cancer patient.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Newly referred cancer patient scheduled for chemotherapy at the Department for Oncology, Vejle Hospital, Region of Southern Denmark
- Aged 18 years and over
- Able to speak and read Danish
- Mentally able to cooperate
- Listed with a general practitioner (98 % of the danish population)
- Written and verbal informed consent given
Exclusion Criteria:
- none

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02716168
Denmark | |
Department of Oncology, Vejle Hospital, Region of Southern Denmark | |
Vejle, Denmark, 7100 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Theis Trabjerg, MD, PhD fellow, University of Southern Denmark |
ClinicalTrials.gov Identifier: | NCT02716168 |
Other Study ID Numbers: |
Partnership-Project |
First Posted: | March 23, 2016 Key Record Dates |
Last Update Posted: | October 20, 2020 |
Last Verified: | October 2020 |
Cancer tele-health Shared care Continuity |